[Form 4] USA COMPRESSION PARTNERS LP Insider Trading Activity

Rhea-AI Filing Summary

Christopher J. Wauson, Vice President and Chief Operating Officer of USA Compression GP, LLC, reported an award of 20,000 restricted common units of USA Compression Partners, LP (USAC) on 08/12/2025. The units were granted at $0 under the Issuer's Long-Term Incentive Plan and increase the reporting person’s beneficial ownership to 44,585 common units. The restricted units vest 60% on December 5, 2027 and 40% on December 5, 2029, and vesting is generally contingent on continued employment with the Issuer or its affiliates.

Positive

• 20,000 restricted units granted under the Long-Term Incentive Plan, aligning executive compensation with company performance and retention
• Clear vesting schedule (60% 12/05/2027; 40% 12/05/2029) disclosed, providing transparency on timing of potential ownership changes
• Post-transaction beneficial ownership disclosed: 44,585 common units, meeting Section 16 reporting requirements

Negative

• None.

Insights

Securities Analyst

TL;DR: A routine long-term incentive grant to a senior executive increases alignment but appears non-material to equity totals.

The Form 4 discloses a non-cash award of 20,000 restricted units vesting over two multi-year tranches, raising the reporting person’s holdings to 44,585 units. This is a standard compensation-related disclosure under Section 16 and provides transparency on insider ownership changes. The transaction carries no exercise price and is contingent on continued employment, indicating retention and alignment objectives rather than immediate transfer of economic value. Based solely on disclosed figures, the award does not appear large enough to meaningfully change control or capital structure.

Corporate Governance Expert

TL;DR: Typical restricted-unit grant for a named officer with multi-year vesting; governance disclosure is complete and timely.

The filing identifies the reporting person, role, and the grant terms: 60% vesting in 2027 and 40% in 2029, contingent on continued employment. The Form 4 includes the reporting person’s relationship to the issuer and the post-transaction beneficial ownership amount, fulfilling Section 16 disclosure requirements. From a governance perspective, the award appears structured for retention and long-term alignment with limited immediate dilution impact based on the reported holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wauson Christopher J.

(Last) (First) (Middle)

8117 PRESTON ROAD

SUITE 510A

(Street)

DALLAS TX 75225

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
USA Compression Partners, LP [ USAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Units	08/12/2025		A		20,000(1)	A	$0	44,585	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. An award of Restricted Units granted under the USA Compression Partners, LP Long-Term Incentive Plan that will vest 60% on December 5, 2027 and 40% on December 5, 2029, generally contingent upon the reporting person's continued employment with USA Compression Partners, LP (the "Issuer") or one of its affiliates on each applicable vesting date.

Remarks:

The Reporting Person is the Vice President and Chief Operating Officer of USA Compression GP, LLC, the general partner of the Issuer (the "General Partner"). The Issuer is managed by the directors and executive officers of the General Partner.

	/s/ Christopher J. Wauson	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did USAC file on Form 4 for Christopher J. Wauson?

The Form 4 reports an award of 20,000 restricted common units granted on 08/12/2025 under the Issuer's Long-Term Incentive Plan.

What is the vesting schedule for the restricted units reported by USAC (Wauson)?

The restricted units vest 60% on December 5, 2027 and 40% on December 5, 2029, generally contingent on continued employment.

How many USAC units does Christopher Wauson beneficially own after the reported transaction?

Following the transaction the reporting person beneficially owns 44,585 common units.

Was there an exercise or purchase price for the granted units in the Form 4?

The grant was reported at a $0 price on the Form 4.

What is Christopher Wauson's role related to USA Compression Partners, LP?

The filing identifies him as the Vice President and Chief Operating Officer of USA Compression GP, LLC, the general partner of the Issuer.